BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 35320899)

  • 1. Association between Complementary and Alternative Medicine Use and Fear of Cancer Recurrence among Breast Cancer Survivors.
    Kim EEH; Kang J
    Korean J Fam Med; 2022 Mar; 43(2):132-140. PubMed ID: 35320899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploring socio-demographic, physical, psychological, and quality of life-related factors related with fear of cancer recurrence in stomach cancer survivors: a cross-sectional study.
    Shin J; Shin DW; Lee J; Hwang J; Lee JE; Cho B; Song YM
    BMC Cancer; 2022 Apr; 22(1):414. PubMed ID: 35428224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relationships between fear of cancer recurrence, spiritual well-being and psychological resilience in non-metastatic breast cancer survivors during the COVID-19 outbreak.
    Koral L; Cirak Y
    Psychooncology; 2021 Oct; 30(10):1765-1772. PubMed ID: 33982371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fear of cancer recurrence in young early-stage breast cancer survivors: the role of metacognitive style and disease-related factors.
    Thewes B; Bell ML; Butow P
    Psychooncology; 2013 Sep; 22(9):2059-63. PubMed ID: 23408595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psychometric Properties of the Short Form of the Fear of Cancer Recurrence Inventory (FCRI) in Chinese Breast Cancer Survivors.
    Peng L; Huang W; Zhang W; Xu Y; Lu F; Zhong L; Chen X; Xu S; Chen W; Li M
    Front Psychiatry; 2019; 10():537. PubMed ID: 31447709
    [No Abstract]   [Full Text] [Related]  

  • 6. Measuring fear of cancer recurrence in survivors of childhood cancer: Development and preliminary validation of the Fear of Cancer Recurrence Inventory (FCRI)-Child and Parent versions.
    Tutelman PR; Chambers CT; Heathcote LC; Fernandez CV; Flanders A; Patton M; Schulte FSM; Guilcher GMT; Simard S; MacLeod J; Stern M
    Psychooncology; 2022 Jun; 31(6):911-919. PubMed ID: 35018689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Initial validation of the Danish version of the Fear of Cancer Recurrence Inventory (FCRI) in colorectal cancer patients.
    Hovdenak Jakobsen I; Jeppesen MM; Simard S; Thaysen HV; Laurberg S; Juul T
    J Cancer Surviv; 2018 Dec; 12(6):723-732. PubMed ID: 30128857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medical, demographic and psychological correlates of fear of cancer recurrence (FCR) morbidity in breast, colorectal and melanoma cancer survivors with probable clinically significant FCR seeking psychological treatment through the ConquerFear study.
    Smith A'; Sharpe L; Thewes B; Turner J; Gilchrist J; Fardell JE; Girgis A; Tesson S; Descallar J; Bell ML; Beith J; Butow P;
    Support Care Cancer; 2018 Dec; 26(12):4207-4216. PubMed ID: 29882025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploring the screening capacity of the Fear of Cancer Recurrence Inventory-Short Form for clinical levels of fear of cancer recurrence.
    Fardell JE; Jones G; Smith AB; Lebel S; Thewes B; Costa D; Tiller K; Simard S; Feldstain A; Beattie S; McCallum M; ; Butow P
    Psychooncology; 2018 Feb; 27(2):492-499. PubMed ID: 28755462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spotlight on the Fear of Cancer Recurrence Inventory (FCRI).
    Smith AB; Costa D; Galica J; Lebel S; Tauber N; van Helmondt SJ; Zachariae R
    Psychol Res Behav Manag; 2020; 13():1257-1268. PubMed ID: 33376421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fear of cancer recurrence among cancer survivors in Singapore.
    Mahendran R; Liu J; Kuparasundram S; Simard S; Chan YH; Kua EH; Griva K
    Singapore Med J; 2021 Jun; 62(6):305-310. PubMed ID: 31989183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fear of cancer recurrence and coping attitudes of breast cancer survivors.
    Oztas B; Ugurlu M; Kurt G
    Eur J Cancer Care (Engl); 2022 Nov; 31(6):e13742. PubMed ID: 36259514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of fear of cancer recurrence on healthcare utilization among long-term breast cancer survivors recruited through ECOG-ACRIN trials.
    Vachon E; Krueger E; Champion VL; Haggstrom DA; Cella D; Cohee AA
    Psychooncology; 2021 Mar; 30(3):279-286. PubMed ID: 33022832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fear of cancer recurrence among Chinese cancer survivors: Prevalence and associations with metacognition and neuroticism.
    Ng DWL; Kwong A; Suen D; Chan M; Or A; Ng SS; Foo CC; Fielding BFS; Lam WWT
    Psychooncology; 2019 Jun; 28(6):1243-1251. PubMed ID: 30932279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fear of Cancer Recurrence in Survivors of Human Papillomavirus-Associated Oropharyngeal Carcinoma.
    Casswell G; Gough K; Drosdowsky A; Bressel M; Coleman A; Shrestha S; D'Costa I; Fua T; Tiong A; Liu C; Rischin D; McDowell L
    Int J Radiat Oncol Biol Phys; 2021 Nov; 111(4):890-899. PubMed ID: 34265396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening and comorbidity of clinical levels of fear of cancer recurrence.
    Simard S; Savard J
    J Cancer Surviv; 2015 Sep; 9(3):481-91. PubMed ID: 25603948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protocol of a randomized controlled trial of the fear of recurrence therapy (FORT) intervention for women with breast or gynecological cancer.
    Maheu C; Lebel S; Courbasson C; Lefebvre M; Singh M; Bernstein LJ; Muraca L; Benea A; Jolicoeur L; Harris C; Ramanakumar AV; Ferguson S; Sidani S
    BMC Cancer; 2016 Apr; 16():291. PubMed ID: 27112319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and factors associated with fear of recurrence in a mixed sample of young adults with cancer.
    Lane BE; Garland SN; Chalifour K; Eaton G; Lebel S; Galica J; Maheu C; Simard S
    J Cancer Surviv; 2019 Dec; 13(6):842-851. PubMed ID: 31468324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Attentional bias and metacognitions in cancer survivors with high fear of cancer recurrence.
    Butow P; Kelly S; Thewes B; Hruby G; Sharpe L; Beith J
    Psychooncology; 2015 Apr; 24(4):416-23. PubMed ID: 25156065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Study protocol for the evaluation of Fear-Less: a stepped-care program for fear of cancer recurrence in survivors with early-stage disease.
    Tran MJ; Jefford M; Smith B; Lynch F; Dhillon HM; Shaw J; McDowell L; White A; Halloran C; Wiesenfeld D; Ftanou M
    Pilot Feasibility Stud; 2022 Aug; 8(1):177. PubMed ID: 35948952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.